COP
36
2
RRC
52
2
HIG
48
5
CTSH
55
3
DG
14
6
LEN
21
3
MMM
35
3
IPG
43
3
GILD
55
5
BAC
38
3
MTCH
62
22
PSX
24
2
ADBE
50
3
ETN
64
4
NKE
36
2
AIG
38
5
CTAS
36
8
XEL
48
11
AON
25
4
ABBV
40
5
COP
36
2
RRC
52
2
HIG
48
5
CTSH
55
3
DG
14
6
LEN
21
3
MMM
35
3
IPG
43
3
GILD
55
5
BAC
38
3
MTCH
62
22
PSX
24
2
ADBE
50
3
ETN
64
4
NKE
36
2
AIG
38
5
CTAS
36
8
XEL
48
11
AON
25
4
ABBV
40
5
Financhill
Back

Krystal Biotech Quote, Financials, Valuation and Earnings

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
25

KRYS
Krystal Biotech

Last Price:
$165.06
Seasonality Move:
4.67%

7 Day Trial

ALL ACCESS PASS

$ 7

The Trump Nuclear MEGA-Boom!

Here's why nuclear stocks are expected to skyrocket under Trump's second term.

Krystal Biotech Price Quote

$165.06
+0.31 (+2.63%)
(Updated: December 21, 2024 at 5:34 AM ET)

Krystal Biotech Key Stats

Sell
25
Krystal Biotech (KRYS) is a Sell
Day range:
$159.20 - $165.98
52-week range:
$107.50 - $219.34
Dividend yield:
0%
P/E ratio:
422.44
P/S ratio:
20.07
P/B ratio:
5.35%
Volume:
886.3K
Avg. volume:
293.9K
1-year change:
45.87%
Market cap:
$4.7B
Revenue:
$50.7M
EPS:
$1.78

How Much Does Krystal Biotech Make?

Data Unavailable

Is Krystal Biotech Growing As A Company?

Data Unavailable

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went down by -7.5% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 45.87% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Krystal Biotech?

Data Unavailable

Is Krystal Biotech Cash Flow Positive?

Data Unavailable

Krystal Biotech Return On Invested Capital

Data Unavailable

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Bioventus Inc (BVS)
    • Amicus Therapeutics Inc (FOLD)
    • Insmed Inc (INSM)

Krystal Biotech Dividend Yield

Data Unavailable

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: -67.38% -3.18%
Revenue: 879.91% 0.88%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 207.78
Upside from Last Price: 26.12%

Major Shareholders

Data Unavailable